<?xml version="1.0" encoding="UTF-8"?>
<xml>
<records>
<record>
	<source-app name="Actavia">Actavia</source-app>
	<ref-type name="Journal Article">0</ref-type>
	<contributors>
		<authors>
			<author>Garout, Mohammed A.</author>
			<author>Jokhdar, Hani A.A.</author>
			<author>Aljahdali, Imad A.</author>
			<author>Zein, Ahmed R.</author>
			<author>Goweda, Reda A.</author>
			<author>Hassan-Hussein, Abdurahman</author>
		</authors>
		<secondary-authors></secondary-authors>
	</contributors>
	<titles><title>Mortality rate of ICU patients with the Middle East Respiratory Syndrome - Coronavirus infection at King Fahad Hospital, Jeddah, Saudi Arabia</title></titles>
	<dates>
		<year>2018</year>
		<pub-dates><date>2018-6-30</date></pub-dates>
	</dates>
	<pages>87-91</pages>
	<abstract>Objective: The Middle East Respiratory Syndrome Coronavirus (MERS-CoV) is a novel coronavirus circulating in the Arabian Peninsula since September 2012. It leads to significant respiratory disease and among patients with co-morbidities is associated with high mortality. This research studied the mortality rate of MERS-CoV among intensive care unit (ICU) patients and the correlation of mortality with different co-morbidities. Methods: This was a retrospective observational study conducted at the Intensive Care Unit of the King Fahad Hospital, Jeddah, Saudi Arabia. Data was obtained through patient chart review. Results: The total sample consisted of 52 laboratory-confirmed MERS-CoV infection patients. 39 patients died, with a 75% case-fatality rate. Many patients had underlying co-morbidities, including diabetes mellitus (51.9%), hypertension (46.2%), and chronic renal disease (21.2%). Conclusions: MERS-CoV ICU mortality remains markedly high due to a combination of factors; the disease process of MERS-CoV leads to multiple organ failure, particularly respiratory and renal failure.</abstract>
	<number>2</number>
	<volume>26</volume>
</record>
</records>
</xml>
